Bavarian Nordic CEO 'Seeking Big Pharma partner' For RSV Vaccine Program

 
• By Sten Stovall
  
RSV
Phase II data suggest a single shot of MVABN RSV induces a broad potent immune response • Source: Shutterstock

More from Clinical Trials

More from R&D